8yr

JONESBORO — Arkansas State University alumnus and Lynn-native Dr. J.B. Penn has made a gift of more than $450,000 to support the innovative trading program jointly developed by the College of Agriculture and the Neil Griffin College of Business at A-State. This transformative donation, held by the Arkansas State University System Foundation Inc., enhances a hands-on initiative that provides students with real-world experience in financial markets. The funds will be used for investments proposed by students, empowering them to apply their skills in futures and commodities trading. “This gift reflects my belief in the importance of equipping students with an understanding of how financial markets influence business operations,” said Penn, who retired from Deere & Co. after serving as its chief economist. “The hands-on experience gained through this program is invaluable for their future success.” The program utilizes the state-of-the-art Dawson Capital Markets Lab in the Griffin College of Business. Established through a gift in 2014 from Scott and Kay Keasler Dawson, the lab features advanced technology for tracking and analyzing financial markets. “The College of Agriculture emphasizes ‘beyond the classroom’ experiences and the Penn Trading program exemplifies that commitment,” said Dr. Mickey LaTour, dean of the College of Agriculture. “We believe that expertise in futures trading will set our students apart from their peers. We are deeply grateful for Dr. Penn’s generous gift which supports this unique initiative and advances our mission to prepare students for leadership in agriculture.” Dr. Jim Washam, dean of the Griffin College of Business, expressed excitement about the partnership. “Given the importance of agricultural business to the regional economy, our two colleges are a natural fit for joint projects,” Washam said. “This collaboration not only strengthens the academic experience but also prepares students for critical roles in the workforce.” Through the trading platform, students will define investment goals, evaluate risks and present recommendations for real-world execution by the foundation. The returns generated will support scholarships, internships, travel and research opportunities for agriculture students. “Dr. J.B. Penn’s generous gift supports the only program of its kind, uniquely equipping our students with unmatched, real-world trading experience across agriculture, energy and metals markets,” said Dr. Jacob Manlove, associate professor of agricultural economics and advisor for the futures and options trading program. “This initiative bridges classroom learning with the practical demands of trading, ensuring our students graduate with a competitive edge that no other program offers.” Penn, who was designated as an A-State Distinguished Alumnus in 2001, earned his Bachelor of Science in Agriculture from A-State before completing advanced degrees in agricultural economics at Louisiana State University and Purdue University. His career included serving as undersecretary for farm and foreign agricultural services at the U.S. Department of Agriculture and providing strategic leadership at Deere & Co.After his team's 102-89 home win on Wednesday night over Purdue Fort Wayne, Penn State coach Mike Rhoades challenged his team's fan base to show up and make more noise. "Sweat with us," he said at one point. At 5-0, the Nittany Lions haven't had to sweat much to get off to a fast start. They might not have to expend much perspiration to make it 6-0 on Monday when they meet Fordham in a semifinal matchup at the Sunshine Slam tournament in Daytona Beach, Fla. Penn State hasn't played a strong schedule so far, but the team has been impressive. It's averaging 98.2 points per game and 13.8 steals per game, both of which ranked second in Division I through Saturday's play. The Nittany Lions were seventh per kenpom.com in turnover rate, forcing 25.3 per 100 possessions. Point guard Ace Baldwin Jr. is leading the charge, scoring 16.4 points and dishing out 7.8 assists while chipping in 2.6 steals. Zach Hicks has nearly doubled his scoring average from 8.4 last season to 15.8 this season, while Northern Illinois transfer Yanic Konan Niederhauser has beefed up the interior, tallying 12.2 points and 7.2 rebounds. Meanwhile, Fordham (3-3) is coming off a 73-71 home loss Friday night against Drexel in New York. The Rams blew a seven-point lead early in the second half and missed a chance to force overtime when leading scorer Jackie Johnson III missed a layup as time expired. Johnson, a UNLV transfer, is averaging 19 points per game and is making nearly 48 percent of his shots as one of three Rams with double-figure scoring averages. Jahmere Tripp scores at an 11.0 clip while Japhet Medor is contributed 10.5, but Fordham is struggling to make shots, canning only 41.5 percent from the field. The Rams were picked for a 14th-place finish in the Atlantic 10 despite returning more scoring than any team in the league except for VCU. Third-year coach Keith Urgo thinks his team can defy low external expectations. "We're experienced and I think we're poised to have a tremendous year," he said. --Field Level Media

Blue Origin and Estes Rockets Join Forces

Drink Spiking Will Be Made A Criminal Offence Under Labour Bid To Protect Women And GirlsHistoSonics Targets Pancreatic Tumors in New Feasibility Study Just about a year ago, Plymouth-based earned . This week, the medtech startup unveiled plans to use the same technology to conquer pancreatic tumors. On Monday, HistoSonics announced that it has successfully treated patients with pancreatic tumors using the Edison system, technology that uses ultrasound to “liquefy” tumors in the body. The patients are part of a new feasibility study in Spain that officially kicked off on Dec. 10. Known as the “ ,” the study seeks to evaluate the safety of Edison in treating pancreatic tumors in up to 30 patients. Why Spain? Although the company has a strong presence here in the Midwest, HistoSonics has a history with the European country. The startup’s 2018 feasibility trial for treating liver tumors, for instance, took place in Barcelona. HistoSonics’ medical director, Dr. Joan Videl-Jove, is a surgical oncologist in Barcelona, and he served as a principal investigator in that earlier study. HistoSonics’ method of treating tumors relies on a process known as “histotripsy,” which the company defines as “a novel non-invasive technology that destroys targeted tumor tissue using focused ultrasound.” In a news release issued Monday, the company noted that pancreatic tumors have the highest mortality rate of any major tumor type. “Most patients with pancreatic tumors face limited treatment options and are ineligible for surgery due to advanced stage of disease,” said Mike Blue, HistoSonics CEO and president, in the release. “We believe histotripsy provides a non-invasive option to target tumors that were previously considered untreatable.” In October 2023, HistoSonics earned the FDA’s “de novo classification,” which permitted the company to begin marketing the Edison system for destroying liver tumors. Notably, the FDA hasn’t yet formally evaluated Edison for treating disease; the agency’s earlier classification sticks with the more general term of “destruction of liver tumors.”Atria Investments Inc acquired a new position in Silgan Holdings Inc. ( NYSE:SLGN – Free Report ) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 4,640 shares of the industrial products company’s stock, valued at approximately $244,000. Other institutional investors and hedge funds have also bought and sold shares of the company. Blue Trust Inc. increased its holdings in shares of Silgan by 256.6% in the 2nd quarter. Blue Trust Inc. now owns 592 shares of the industrial products company’s stock worth $25,000 after buying an additional 426 shares during the last quarter. Versant Capital Management Inc boosted its holdings in shares of Silgan by 2,838.5% in the 2nd quarter. Versant Capital Management Inc now owns 1,146 shares of the industrial products company’s stock worth $49,000 after purchasing an additional 1,107 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Silgan by 109.9% during the 2nd quarter. GAMMA Investing LLC now owns 1,171 shares of the industrial products company’s stock valued at $50,000 after purchasing an additional 613 shares during the last quarter. Headlands Technologies LLC purchased a new stake in Silgan in the second quarter worth approximately $70,000. Finally, Meeder Asset Management Inc. bought a new position in Silgan during the second quarter valued at approximately $104,000. 70.25% of the stock is owned by hedge funds and other institutional investors. Wall Street Analyst Weigh In A number of equities research analysts have recently weighed in on SLGN shares. Truist Financial restated a “buy” rating and issued a $59.00 price objective (up from $56.00) on shares of Silgan in a report on Thursday, August 1st. Wells Fargo & Company raised their price objective on Silgan from $54.00 to $58.00 and gave the company an “overweight” rating in a research note on Thursday, August 1st. Royal Bank of Canada boosted their target price on Silgan from $55.00 to $58.00 and gave the company an “outperform” rating in a research note on Friday, November 1st. Citigroup raised their price target on Silgan from $50.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. Finally, StockNews.com cut Silgan from a “buy” rating to a “hold” rating in a research note on Wednesday, October 9th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $57.43. Silgan Stock Up 1.7 % Shares of NYSE:SLGN opened at $56.53 on Friday. Silgan Holdings Inc. has a 1 year low of $40.88 and a 1 year high of $56.78. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.09 and a quick ratio of 0.75. The stock’s 50-day moving average is $52.29 and its 200 day moving average is $48.91. The company has a market cap of $6.04 billion, a PE ratio of 20.48, a P/E/G ratio of 1.46 and a beta of 0.67. Silgan ( NYSE:SLGN – Get Free Report ) last announced its earnings results on Wednesday, October 30th. The industrial products company reported $1.21 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.02). The business had revenue of $1.75 billion for the quarter, compared to the consensus estimate of $1.82 billion. Silgan had a net margin of 5.11% and a return on equity of 18.76%. Silgan’s revenue was down 3.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.16 EPS. Sell-side analysts anticipate that Silgan Holdings Inc. will post 3.6 EPS for the current year. Silgan Dividend Announcement The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Monday, December 2nd will be paid a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date is Monday, December 2nd. Silgan’s payout ratio is 27.54%. Silgan Profile ( Free Report ) Silgan Holdings Inc, together with its subsidiaries, manufactures and sells rigid packaging solutions for consumer goods products in the United States and internationally. It operates through three segments: Dispensing and Specialty Closures, Metal Containers, and Custom Containers. The Dispensing and Specialty Closures segment offers a range of metal and plastic closures, and dispensing systems for food, beverage, health care, garden, home, personal care, beauty products, and hard surface cleaning products, as well as capping/sealing equipment and detection systems. Featured Articles Want to see what other hedge funds are holding SLGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Silgan Holdings Inc. ( NYSE:SLGN – Free Report ). Receive News & Ratings for Silgan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silgan and related companies with MarketBeat.com's FREE daily email newsletter .

Monport Laser Unwraps the "Christmas Laser Bonanza" - Spark Your Creativity with Unbeatable Festive OffersUnderstanding Telescope Mounts: Alt-Azimuth vs. EquatorialWhakatāne youth heartbroken after mural hit by graffiti